scispace - formally typeset
A

Anna Caciotti

Researcher at Boston Children's Hospital

Publications -  41
Citations -  1053

Anna Caciotti is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: GLB1 & Gangliosidosis. The author has an hindex of 19, co-authored 36 publications receiving 893 citations. Previous affiliations of Anna Caciotti include University of Florence.

Papers
More filters
Journal Article

Activation of cam promoterless gene by ISR10 transposition in an Escherichia coli population under stress conditions

TL;DR: Sequence analysis of plasmid DNA extracted from E. coli Cam r colonies revealed that the insertion of IS10R mobile element, transposed from the bacterial chromosome, occur- red soon upstream of cam gene rendering it transcriptable by the host RNA-polymerase, allowing the surviving of the E.E. coli cells in the presence of the antibiotic.
Journal ArticleDOI

Case Report: Dramatic Cholestasis Responsive to Steroids in a Newborn Homozygous for H63D HFE Variant

TL;DR: In a newborn with very precocious liver failure, cholestatic jaundice, and low γ-glutamyl transpeptidase, progressive hepatosplenomegaly induced a progressively worsening respiratory distress, that was successfully treated with steroids, it is suggested that hereditary hemochromatosis ought to be included in the panel of the possible causes of neonatalCholestasis.
Journal ArticleDOI

3-Methylglutaconic Aciduria Type I Due to AUH Defect: The Case Report of a Diagnostic Odyssey and a Review of the Literature

TL;DR: The case of a 31-month-old female child referred to the authors' center after the detection of increased 3-hydroxyisovalerylcarnitine levels at newborn screening and the presence of two microdeletions in compound heterozygosity encompassing the AUH gene, which confirmed the diagnosis of MGCA1, exemplifies the importance of the biochemical phenotype in the differential diagnosis of metabolic diseases.
Journal ArticleDOI

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis

TL;DR: Five new trihydroxypiperidine iminosugars are synthesized with the aim of identifying new pharmacological chaperones for GM1 gangliosidosis and compound 12 showed chaperoning properties since it enhanced β-Gal activity by 40% when tested on GM1 patients bearing the p.Ile51Asn/p.Arg201His mutations.
Journal ArticleDOI

Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann–Pick Type C

TL;DR: It is demonstrated that with the methods, it is possible to clearly distinguish the levels of accumulated metabolites in fibroblasts from affected and unaffected patients for all the three pathologies considered, and the methods proved to be rapid, sensitive, unbiased, and potentially applicable to other LSDs.